These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 31180529
1. Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells. Milani R, Brognara E, Fabbri E, Manicardi A, Corradini R, Finotti A, Gasparello J, Borgatti M, Cosenza LC, Lampronti I, Dechecchi MC, Cabrini G, Gambari R. Int J Oncol; 2019 Jul; 55(1):59-68. PubMed ID: 31180529 [Abstract] [Full Text] [Related]
2. High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222. Brognara E, Fabbri E, Montagner G, Gasparello J, Manicardi A, Corradini R, Bianchi N, Finotti A, Breveglieri G, Borgatti M, Lampronti I, Milani R, Dechecchi MC, Cabrini G, Gambari R. Int J Oncol; 2016 Mar; 48(3):1029-38. PubMed ID: 26708164 [Abstract] [Full Text] [Related]
3. Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. Brognara E, Fabbri E, Bazzoli E, Montagner G, Ghimenton C, Eccher A, Cantù C, Manicardi A, Bianchi N, Finotti A, Breveglieri G, Borgatti M, Corradini R, Bezzerri V, Cabrini G, Gambari R. J Neurooncol; 2014 May; 118(1):19-28. PubMed ID: 24595467 [Abstract] [Full Text] [Related]
4. Synergistic effects of the combined treatment of U251 and T98G glioma cells with an anti‑tubulin tetrahydrothieno[2,3‑c]pyridine derivative and a peptide nucleic acid targeting miR‑221‑3p. Zurlo M, Romagnoli R, Oliva P, Gasparello J, Finotti A, Gambari R. Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278445 [Abstract] [Full Text] [Related]
5. Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells. Bertucci A, Prasetyanto EA, Septiadi D, Manicardi A, Brognara E, Gambari R, Corradini R, De Cola L. Small; 2015 Nov 11; 11(42):5687-95. PubMed ID: 26395266 [Abstract] [Full Text] [Related]
6. High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p. Gasparello J, Gambari L, Papi C, Rozzi A, Manicardi A, Corradini R, Gambari R, Finotti A. Nucleic Acid Ther; 2020 Jun 11; 30(3):164-174. PubMed ID: 32069125 [Abstract] [Full Text] [Related]
7. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G. Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279 [Abstract] [Full Text] [Related]
8. LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathway. Yang C, He L, Chen G, Ning Z, Xia Z. Hum Cell; 2019 Jan 10; 32(1):41-50. PubMed ID: 30426452 [Abstract] [Full Text] [Related]
9. Overexpression of ILK promotes temozolomide resistance in glioma cells. Liang F, Wang B, Bao L, Zhao YS, Zhang SM, Zhang SQ. Mol Med Rep; 2017 Mar 10; 15(3):1297-1304. PubMed ID: 28138714 [Abstract] [Full Text] [Related]
10. Effect of IFN-beta on human glioma cell lines with temozolomide resistance. Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E. Int J Oncol; 2009 Jul 10; 35(1):139-48. PubMed ID: 19513561 [Abstract] [Full Text] [Related]
11. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells. Chio CC, Chen KY, Chang CK, Chuang JY, Liu CC, Liu SH, Chen RM. BMC Cancer; 2018 Apr 03; 18(1):379. PubMed ID: 29614990 [Abstract] [Full Text] [Related]
12. Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy. Qian X, Ren Y, Shi Z, Long L, Pu P, Sheng J, Yuan X, Kang C. Mol Pharm; 2012 Sep 04; 9(9):2636-45. PubMed ID: 22853427 [Abstract] [Full Text] [Related]
13. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z. Brain Res; 2010 Sep 17; 1352():255-64. PubMed ID: 20633539 [Abstract] [Full Text] [Related]
14. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells. Han J, Chen Q. Int J Clin Exp Pathol; 2015 Sep 17; 8(10):12698-707. PubMed ID: 26722459 [Abstract] [Full Text] [Related]
15. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. Kanzawa T, Bedwell J, Kondo Y, Kondo S, Germano IM. J Neurosurg; 2003 Dec 17; 99(6):1047-52. PubMed ID: 14705733 [Abstract] [Full Text] [Related]
16. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation. Yu G, Wu F, Wang E. Cell Physiol Biochem; 2016 Dec 17; 38(4):1596-604. PubMed ID: 27081861 [Abstract] [Full Text] [Related]
17. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species. Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G. Cancer Lett; 2018 Oct 28; 435():66-79. PubMed ID: 30081068 [Abstract] [Full Text] [Related]
18. Gene expression profiling predicts response to temozolomide in malignant gliomas. Yoshino A, Ogino A, Yachi K, Ohta T, Fukushima T, Watanabe T, Katayama Y, Okamoto Y, Naruse N, Sano E, Tsumoto K. Int J Oncol; 2010 Jun 28; 36(6):1367-77. PubMed ID: 20428759 [Abstract] [Full Text] [Related]
19. Downregulation of miR-196b Promotes Glioma Cell Sensitivity to Temozolomide Chemotherapy and Radiotherapy. Ma R, Zheng G, Shao C, Liu J, Lv H, Zhang G. Ann Clin Lab Sci; 2018 Nov 28; 48(6):719-725. PubMed ID: 30610041 [Abstract] [Full Text] [Related]
20. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells. Ma J, Yang YR, Chen W, Chen MH, Wang H, Wang XD, Sun LL, Wang FZ, Wang DC. Oncol Rep; 2016 Aug 28; 36(2):676-84. PubMed ID: 27278525 [Abstract] [Full Text] [Related] Page: [Next] [New Search]